<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04860791</url>
  </required_header>
  <id_info>
    <org_study_id>20-PP-03</org_study_id>
    <nct_id>NCT04860791</nct_id>
  </id_info>
  <brief_title>Validation of the French Adaptation of the MSWDQ-23 Questionnaire</brief_title>
  <acronym>WORKSEP</acronym>
  <official_title>Validation Study of the French Adaptation of the MSWDQ-23 Questionnaire, a Tool Assessing the Work Difficulties of Patients With Multiple Sclerosis.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Centre Hospitalier Universitaire de Nice</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Centre Hospitalier Universitaire de Nice</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      MS is an autoimmune disease of the central nervous system that affects more than 120,000&#xD;
      people in France. The average age of onset of the disease is between 25 and 35 years. Given&#xD;
      the wide range of ages of the patients, from 4 to 80 years, the ethical and socio-economic&#xD;
      stakes are high in order to maintain their autonomy, sociability, family and intimate life,&#xD;
      and their employment in the best possible conditions and for as long as possible.&#xD;
&#xD;
      However, to date, there are no evaluation tools in French that allow us to understand the&#xD;
      difficulties at work of MS patients.&#xD;
&#xD;
      The Multiple Sclerosis Work Difficulties Questionnaire (MSWDQ-23) was developed specifically&#xD;
      for MS patients and validated in English [1]. There is a short version of this questionnaire&#xD;
      that facilitates its use in clinical practice [2]. It has been translated and validated in&#xD;
      Spanish through a multicenter study, and is currently being validated in German, but does not&#xD;
      currently exist in French [3]. The main objective of the WORKSEP project is to validate the&#xD;
      French version of this questionnaire through a multicenter population-based cohort within the&#xD;
      framework of the French-speaking Multiple Sclerosis Society (SFSEP). This validation study&#xD;
      will involve the inclusion of 206 French-speaking MS patients, regardless of their&#xD;
      professional status, all forms of MS combined, from the early stage (Clinically Isolated&#xD;
      Syndrome) to the more advanced stages (primary and secondary progressive forms).&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">May 10, 2021</start_date>
  <completion_date type="Anticipated">May 1, 2022</completion_date>
  <primary_completion_date type="Anticipated">May 1, 2022</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Other</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>MSWDQ-23 score</measure>
    <time_frame>1 day</time_frame>
    <description>total score out of 100</description>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">206</enrollment>
  <condition>Multiple Sclerosis</condition>
  <arm_group>
    <arm_group_label>Multiple Sclerosis patients</arm_group_label>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>questionnaires</intervention_name>
    <description>Patients will complete the MSWDQ-23 in French, as well as the DEX, questionnaire for the evaluation of executive dysfunction in daily life, to evaluate their cognitive complaints and the SF36 questionnaire to evaluate their quality of life</description>
    <arm_group_label>Multiple Sclerosis patients</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        French-speaking MS patients with or without cognitive complaints and regardless of their&#xD;
        occupational status will be prospectively recruited at their scheduled disease follow-up&#xD;
        consultation&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Age between 18 and 65 years old.&#xD;
&#xD;
          -  Native French speaker.&#xD;
&#xD;
          -  A diagnosis of Clinically Isolated Syndrome or MS defined according to the 2017&#xD;
             McDonald criteria.&#xD;
&#xD;
          -  Be affiliated with the social security system.&#xD;
&#xD;
          -  Agree to participate in the study.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
        Opposition to the use of the data&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>heloise JOLY</last_name>
    <phone>06.18.75.50.85</phone>
    <email>joly.h@chu-nice.fr</email>
  </overall_contact>
  <location>
    <facility>
      <name>Besancon University Hospital</name>
      <address>
        <city>Besançon</city>
        <zip>25030</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>eric berger</last_name>
      <email>eberger@chu-besancon.fr</email>
    </contact>
    <investigator>
      <last_name>eric berger</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Bordeaux university hospital</name>
      <address>
        <city>Bordeaux</city>
        <zip>33404</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>aurelie ruet</last_name>
      <email>aurelie.ruet@chu-bordeaux.fr</email>
    </contact>
    <investigator>
      <last_name>aurelie ruet</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Caen university hospital</name>
      <address>
        <city>Caen</city>
        <zip>14033</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>nathalie derache</last_name>
      <email>derache-n@chu-caen.fr</email>
    </contact>
    <investigator>
      <last_name>nathalie derache</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Clermont Ferrand university hospital</name>
      <address>
        <city>Clermont-Ferrand</city>
        <zip>63003</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>pierre clavelou</last_name>
      <email>pclavelou@chu-clermontferrand.fr</email>
    </contact>
    <investigator>
      <last_name>pierre clavelou</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Gonesse hospital</name>
      <address>
        <city>Gonesse</city>
        <zip>95503</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>eric manchon</last_name>
      <email>eric.manchon@ch-gonesse.fr</email>
    </contact>
    <investigator>
      <last_name>eric manchon</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Libourne hospital</name>
      <address>
        <city>Libourne</city>
        <zip>33505</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>arnaud gagnol</last_name>
      <email>arnaud.gagnol@ch-libourne.fr</email>
    </contact>
    <investigator>
      <last_name>arnaud gagnol</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Lille University Hospital</name>
      <address>
        <city>Lille</city>
        <zip>59000</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Hélène ZEPHIR</last_name>
      <email>Thi-helene.ZEPHIR@CHRU-LILLE.FR</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Groupement des Hôpitaux de l'Institut Catholique de Lille</name>
      <address>
        <city>Lomme</city>
        <zip>59462</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>cecile donze</last_name>
      <email>donze.cecile@ghicl.net</email>
    </contact>
    <investigator>
      <last_name>cecile donze</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Lyon University Hospital</name>
      <address>
        <city>Lyon</city>
        <zip>69229</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>sandra VUKUSIC</last_name>
      <email>sandra.vukusic@chu-lyon.fr</email>
    </contact>
    <investigator>
      <last_name>sandra vukusik</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Marseille University Hospital</name>
      <address>
        <city>Marseille</city>
        <zip>13000</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Jean Pelletier</last_name>
      <email>jean.pelletier@ap-hm.fr</email>
    </contact>
    <investigator>
      <last_name>jean pelletier</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Nancy Hospital</name>
      <address>
        <city>Nancy</city>
        <zip>54000</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Helene Brissart</last_name>
      <email>h.brissart@chru-nancy.fr</email>
    </contact>
    <investigator>
      <last_name>helene brissart</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Nimes university hospital</name>
      <address>
        <city>Nîmes</city>
        <zip>30029</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>eric Thouvenot</last_name>
      <email>eric.thouvenot@chu-nimes.fr</email>
    </contact>
    <investigator>
      <last_name>eric thouvenot</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>APHP</name>
      <address>
        <city>Paris</city>
        <zip>75651</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Celine LOUARPE</last_name>
      <email>celine.louarpe@aphp.fr</email>
    </contact>
    <investigator>
      <last_name>celine louarpe</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Rouen univestity hospital</name>
      <address>
        <city>Rouen</city>
        <zip>76000</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>bertrand Bourre</last_name>
      <email>bertrand.bourre@chu-rouen.fr</email>
    </contact>
    <investigator>
      <last_name>bertrand bourre</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Saint Etienne University Hospital</name>
      <address>
        <city>Saint-Étienne</city>
        <zip>42055</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>jean-philippe camdessanche</last_name>
      <email>j.philippe.camdessanche@chu-st-etienne.fr</email>
    </contact>
    <investigator>
      <last_name>jean-philippe camdessanche</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Strasnourg university hospital</name>
      <address>
        <city>Strasbourg</city>
        <zip>67000</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>jerome de seze</last_name>
      <email>Jerome.DESEZE@chru-strasbourg.fr</email>
    </contact>
    <investigator>
      <last_name>jerome de seze</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>July 2021</verification_date>
  <study_first_submitted>April 23, 2021</study_first_submitted>
  <study_first_submitted_qc>April 23, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">April 27, 2021</study_first_posted>
  <last_update_submitted>July 21, 2021</last_update_submitted>
  <last_update_submitted_qc>July 21, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">July 22, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Multiple Sclerosis</mesh_term>
    <mesh_term>Sclerosis</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

